Levomoprolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C13H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K4NON6FSON, chemically known as 2-propanol, 1-(2-methoxyphenoxy)-3-((1-methylethyl)amino)-, (s)- but generally known as levomoprolol, which bears US NIH Compound Identifier 3034006. European Medicines Agency schedules Levomoprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08480MIG. The term LEVOMOPROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). LEVOMOPROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levomoprolol under HS 29221980 and SITC 51461. As of Q4 2014, LEVOMOPROLOL remains the US FDA Preferred Term for this commodity. Levomoprolol bears US NLM identifiers UMLS ID C0125658 and NCI Concept Code C83877. SMILES: O(CC(O)CNC(C)C)C1C(OC)CCCC1.